Literature DB >> 24513067

[Application of computer-aided design and navigation technology in skull base and infratemporal fossa tumor surgery].

Yu-xing Guo1, Xin Peng1, Xiao-jing Liu1, Lei Zhang1, Guang-yan Yu1, Chuan-bin Guo2.   

Abstract

OBJECTIVE: To evaluate the application of computer-aided design and navigation technology in skull base and infratemporal fossa tumor surgery and to analyze its advantages and disadvantages.
METHODS: Twenty-nine cases with tumor of skull base and infratemporal fossa were treated with computer-aided design and navigation surgery. The Parameters of age, gender, primary or recurrent tumor, tumor nature and surgical approach were recorded.
RESULTS: En bloc resection was performed in 20 cases and subtotal resection in 9 cases. The margin status was negative margin in 8 cases, near-tumor margin in 17 cases and positive resection margin in 4 cases. Postoperative complication rate was 14% (4/29). During the follow-up period, 2 benign cases recurred.In the malignant group, there were 7 cases of recurrence, 2 cases of metastasis and 3 deaths. The 5-year overall survival and progression-free survival rate were 69% and 40% respectively.
CONCLUSIONS: Navigation technology can enhance the confidence of the surgeons and operation safety in handling malignant tumors in skull base and infratemporal fossa.

Entities:  

Mesh:

Year:  2013        PMID: 24513067

Source DB:  PubMed          Journal:  Zhonghua Kou Qiang Yi Xue Za Zhi        ISSN: 1002-0098


  2 in total

1.  [Multimodal image fusion technology for diagnosis and treatment of the skull base-infratemporal tumors].

Authors:  R Yang; Q X Li; C Mao; X Peng; Y Wang; Y X Guo; C B Guo
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-02-18

2.  CT-MRI Image Fusion-Based Computer-Assisted Navigation Management of Communicative Tumors Involved the Infratemporal-Middle Cranial Fossa.

Authors:  Rong Yang; Han Lu; Yang Wang; Xin Peng; Chi Mao; Zhiqiang Yi; Yuxing Guo; Chuanbin Guo
Journal:  J Neurol Surg B Skull Base       Date:  2020-02-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.